Friday, 19 April 2024
Cascadian Therapeutics Inc.
05:30 | 8/2/18
Post Analyst
Also, BlackBerry Limited (BB) needs to expand a 71.18% increase it experienced over the past twelve months. Cascadian Therapeutics, Inc. (NASDAQ:CASC) Consensus Call At 3. As regular trading ended, Cascadian Therapeutics, Inc. (CASC) stock brought in a ...
more»
Analysts expect Cascadian Therapeutics, Inc. (NASDAQ:CASC) to report $-0.29 EPS on March, 8.They anticipate $0.18 EPS change or 38.30 % from last quarter's $-0.47 EPS.
more»
05:18 | 7/2/18
PR Newswire
BERWYN, Pa., Feb. 6, 2018 /PRNewswire/ -- RM LAW, P.C. is investigating potential claims against the board of directors of Cascadian Therapeutics, Inc. ("Cascadian Therapeutics" or the "Company") (NASDAQ: CASC) concerning possible breaches of fiduciary ...
more»
06:26 | 6/2/18
Digital Journal
The investigation was announced for investors, who currently hold NASDAQ:CASC shares, concerning whether the takeover of Cascadian Therapeutics Inc by Seattle Genetics, Inc for $10.00 per share is unfair.
more»
05:30 | 6/2/18
Post Analyst
Cascadian Therapeutics, Inc. (NASDAQ:CASC) recently had a high trading volume day. The volume for the company on 02-Feb-18 was recorded to be 1.58 million contracts. Over the past three months, the average daily trading volume came in at about 0.74 ...
more»
02:07 | 6/2/18
Post Registrar
Cascadian Therapeutics Inc (NASDAQ:CASC)'s share price soared 0% or 0 to reach at $9.96 during previous trading session.
more»
01:22 | 6/2/18
Economic News
Cascadian Therapeutics, Inc. (NASDAQ:CASC) and Inovio Pharmaceuticals, Inc. (NASDAQ:INO) are both Healthcare companies that recently hit new highs.
more»
14:52 | 1/2/18
BioWorld Online
Seattle Genetics Inc. (Seagen) showed it fully recovered from last year's ill-fated pact with Immunomedics Inc. by nabbing Cascadian Therapeutics Inc. - lock, stock and barrel - for $10 per share in cash, valuing the transaction at approximately $614 ...
more»
Join Us: Get the most advanced premium research delivered to your inbox along with access to visual tools and data that until now has only been made available to the top 1%.
more»
08:52 | 29/11/17
The Ledger Gazette
Follow Us ... Cascadian Therapeutics logo Media headlines about Cascadian Therapeutics (NASDAQ:CASC) have been trending somewhat positive on Tuesday, according to Accern Sentiment Analysis.
more»
Code | Last | Change |
COMP | 10,321 | 328 | | 3.08% |
DJI | 29,635 | 404 | | 1.34% |
SP500 | 3,583 | 87 | | 2.37% |
DAX | 12,438 | 82 | | 0.67% |
FTSE | 7,488 | 5 | | 0.07% |
NI225 | 22,420 | 408 | | 1.86% |
TWI | 67.27 | 0.00 | | 0.00% |